Australia markets open in 1 hour 33 minutes

Algernon Pharmaceuticals Inc. (AGNPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.08230.0000 (0.00%)
At close: 02:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
906.566
1,095
2,293
4,797
2,675
Selling general and administrative
2,811
3,937
3,495
3,081
5,776
Total operating expenses
3,884
5,242
6,020
8,051
8,661
Operating income or loss
-3,884
-5,242
-6,020
-8,051
-8,661
Total other income/expenses net
-
-1,541
-36.479
305.117
87.773
Income before tax
-5,423
-6,781
-6,054
-7,734
-8,538
Income from continuing operations
-5,423
-6,781
-6,054
-7,734
-8,538
Net income
-5,423
-6,781
-6,054
-7,734
-8,538
Net income available to common shareholders
-5,423
-6,781
-6,054
-7,734
-8,538
Basic EPS
-0.45
-0.45
-0.87
-1.04
-2.03
Diluted EPS
-0.45
-0.45
-0.87
-1.04
-2.03
Basic average shares
15,147
15,147
6,953
7,436
4,205
Diluted average shares
15,147
15,147
6,953
7,436
4,205